Get started
Author

Isabel Palacio Vázquez

Observed names: I. Palacio Vazquez, I. Palacio Vázquez, I. Vazquez, Isabel Palacio Vazquez, Isabel Palacio-Vazquez, Isabel Palacio-Vázquez
ORCID: 0000-0001-5142-0150
Observed ORCID: 0000-0001-5142-0150
OpenAlex ID: A5103246001
Mechanisms behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It
2016 · Maria Luque-Cabal, Paula García-Teijido, et al. · Clinical Medicine Insights Oncology · 190
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial
2024 · Nicoletta Colombo, Elena Biagioli, et al. · The Lancet Oncology · 156
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial
2018 · Amit M Oza, Ursula A Matulonis, et al. · The Lancet Oncology · 130
Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial
2019 · Ignace Vergote, Giovanni Scambia, et al. · The Lancet Oncology · 94
PDF
Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial
2019 · Michel Fabbro, Kathleen N. Moore, et al. · Gynecologic Oncology · 52
PDF
Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial
2021 · Keiichi Fujiwara, Hiroyuki Fujiwara, et al. · Journal of Gynecologic Oncology · 12
Quality of life in patients with recurrent ovarian cancer (OC) treated with niraparib: Results from the ENGOT-OV16/NOVA Trial
2017 · A.M. Oza, U.A. Matulonis, et al. · Annals of Oncology · 11
PDF
Safety and Efficacy of Niraparib in Elderly Patients (Pts) with Recurrent Ovarian Cancer (OC)
2017 · M. Fabbro, K.N. Moore, et al. · Annals of Oncology · 9
Protocolo diagnóstico y terapéutico de la mucositis por quimioterapia
2001 · I. Palacio Vázquez, M.aT. Velasco González, et al. · Medicine - Programa de Formación Médica Continuada Acreditado · 4
Long-term safety assessment of niraparib in patients with recurrent ovarian cancer: results from the ENGOT-OV16/NOVA trial
2019 · M.R. Mirza, A. Dørum, et al. · International Journal of Gynecological Cancer · 3
761P A phase II trial of avelumab in combination with pegylated liposomal doxorubicin in recurrent/metastatic endometrial cancer (GEICO 70-E): analysis according to molecular classification
2023 · J.M. Piulats Rodriguez, I. Palacio Vazquez, et al. · Annals of Oncology · 1
PDF
28eP Depth of response to primary POMB/ACE chemotherapy predicts survival in poor prognosis germ-cell tumours
2026 · E. Hobbs, L. Ulrich, et al. · ESMO rare cancers.
87P Health-related quality of life (HRQoL) with maintenance niraparib: 6-month preliminary results from the MONITOR-UK trial
2025 · S. Peleg Hasson, R. Bowen, et al. · ESMO Open
PDF
757P Sustained long-term responders to niraparib maintenance in recurrent platinum-sensitive high-grade ovarian cancer (PSROC): A subanalysis of the GEICO-88R study
2024 · J.F. Cueva Banuelos, I. Palacio Vazquez, et al. · Annals of Oncology
PDF
52P MONITOR-UK: An initial analysis of a multi-centre, observational study of maintenance niraparib in ovarian cancer
2024 · S. Peleg Hasson, R. Bowen, et al. · ESMO Open
Laboratory cross-comparison of homologous recombination repair mutation analysis in tumor in a multicenter epithelial ovarian cancer series: The BORNEO GEICO 60-0 study.
2021 · Ignacio Romero, Ana Oaknin, et al. · Journal of Clinical Oncology
Laboratory cross-comparison of tumor BRCA1/2 analysis in a multicenter epithelial ovarian cancer series: The BORNEO GEICO60-0 study.
2020 · Ignacio Romero, Ana Oaknin, et al. · Journal of Clinical Oncology
Optimizing the febrile neutropenia care process in cancer patients in a third level Spanish hospital.
2020 · Maria Pilar Solis-Hernandez, Luka Mihic Góngora, et al. · Journal of Clinical Oncology
Melanoma
2001 · J. Santos-Juanes Jiménez, I. Palacio Vázquez, et al. · Medicine - Programa de Formación Médica Continuada Acreditado
Tratamiento citostático del carcinoma de mama avanzado: estudios de fase II
1994 · Isabel Palacio Vázquez · Dialnet (Universidad de la Rioja)
Works count: 20
Citation count: 662
H-index: 8
I10-index: 7
Year
Topic
Type